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Background: Balance training has been demonstrated to improve postural control in patients with Par-
kinson's disease (PD). The objective of this pilot randomized clinical trial was to investigate whether a
balance training program using augmented visual feedback is feasible, safe, and more effective than
conventional balance training in improving postural control in patients with PD.
Methods: Thirty-three patients with idiopathic PD participated in a ﬁve-week training program con-
sisting of ten group treatment sessions of 60 min. Participants were randomly allocated to (1) an
experimental group who trained on workstations consisting of interactive balance games with explicit
augmented visual feedback (VFT), or (2) a control group receiving conventional training. Standing bal-
ance, gait, and health status were assessed at entry, at six weeks, and at twelve weeks follow-up.
Results: Sixteen patients were allocated to the control group and seventeen to the experimental group.
The program was feasible to apply and took place without adverse events. Change scores for all balance
measures favored VFT, but the change in the primary outcome measure, i.e. the Functional Reach test, did
not differ between groups (t(28) ¼ -0.116, p ¼ .908). No other differences between groups were statis-
tically signiﬁcant.
Conclusions: VFT proved to be a feasible and safe approach to balance therapy for patients with PD. In
this proof-of-concept study VFT was not superior over conventional balance training although observed
trends mostly favored VFT. These trends approached clinical relevance only in few cases: increasing the
training load and further optimization of VFT may strengthen this effect.
Trial registration: Controlled Trials, ISRCTN47046299.
© 2014 Elsevier Ltd. All rights reserved.1. Introduction
Individuals suffering from Parkinson's disease (PD) will, over
time, typically be confronted with increasing difﬁculties with
walking, balance, and making transfers [1]. This is important as
mobility-related quality of life is closely linked to social participa-
tion [2] while impaired postural control contributes signiﬁcantly to
falls [3]. Balance and gait-related symptoms tend to be largelyrcvandenheuvel@gmail.comresistant to pharmacological treatment [4]. Allied health therapies
such as exercise programs are therefore often implemented to
improve mobility [5,6]. A recent meta-analysis suggests that
balance-oriented training programs can address mobility-related
deﬁcits in patients with PD, but stresses that current evidence is
inconclusive [6].
Biofeedback appears to be a promising means to deliver bal-
ance therapy [7]. Recent technological developments in the
gaming industry have seen integration of players' own physical
movements with virtual environments, furnishing new opportu-
nities to provide explicit augmented visual feedback that engages
the patient in cognitive and motor activities simultaneously [8].
For PD patients serious games may be particularly valuable
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function [9]. Commercially available game consoles with games
that target balance control and other forms of physical capacity
(e.g. Nintendo Wii™ Fit) are increasingly used in rehabilitation
[10]. Pilot studies suggest that (home-based) exercise using Wii
Fit is feasible in patients with mild PD and may improve measures
of balance and gait, activities of daily living, and self-conﬁdence
[11,12]. However, a single randomized clinical trial (RCT) that
compared Wii-based training with conventional balance therapy
for PD patients found no additional beneﬁts over control treat-
ment in improving daily activities, balance, and cognitive per-
formance [13]. A systematic review by Barry et al. concluded that
the safety and clinical effectiveness of exercise-based computer
games in general has not been established sufﬁciently [10]. In
addition, the games and equipment may not be optimized for use
with patients with PD, compromising user experience and safety
[10]. The clinical utility of Wii Fit for instance, appears to be
limited by the extent to which therapists can adjust parameters
such as exercise complexity, speed, and workload [10]. Progres-
sively modifying exercises in terms of dose and intensity is a key
aspect of adequate physical training [14]. These shortcomings can
be addressed by employing equipment that is designed for use in
a clinical setting, with special attention for patients who experi-
ence severe mobility-related difﬁculties. This might improve
effectiveness and applicability of visual feedback techniques in
balance training.
In the present pilot RCT we investigated the feasibility of vi-
sual feedback-based balance training (VFT) speciﬁcally designed
for clinical therapeutic settings in terms of applicability and
safety. In addition, we compared the effects of the training pro-
gram with conventional balance training in patients with PD. We
hypothesized that VFT can be applied safely and more effectively
than conventional training to improve standing balance
performance.
2. Methods
2.1. Design
We compared two parallel treatment groups of PD patients. A detailed
description of the study protocol was reported previously [15]. This study was
registered as an International Standard Randomised Controlled Trial under
ISRCTN47046299.
Assessments took place at entry prior to randomization (T0), at six weeks (T1),
and at 12 weeks (T2) follow-up. A ﬁve-week training program was conducted be-
tween T0 and T1. All assessments and training sessions were performed in the ON-
phase of levodopa medication.Fig. 1. Illustration of the intervention in the experimental group. A: Setup of mobile work
games. (Reproduced from Ref. [15]).2.2. Participants
A total of 33 patients with idiopathic PD were recruited from patient databases
of the Department of Rehabilitation Medicine of VU University Medical Center
(VUmc). Inclusion criteria were (i) a diagnosis of idiopathic PD according to the UK
Brain Bank criteria [16], mild to moderate stage (i.e. Hoehn & Yahr stages II and III),
(ii) able to participate in either training program, and (iii) written and verbal
informed consent. Exclusion criteria were the (i) presence of (other) neurological,
orthopedic, or cardiopulmonary problems that could impair participation, (ii) Mini
Mental State Examination (MMSE) score below 24, (iii) a recent change in dopa-
minergic medication, and (iv) cognitive, visual, and/or language problems impeding
participation. Participants did not receive other physical therapy treatments during
the study period.
2.3. Intervention
Both groups received two treatment sessions per week for a period of ﬁveweeks
in the outpatient clinic of VUmc. Each session lasted 60 min of which 45 min were
dedicated to a series of workstations aimed to improve standing balance perfor-
mance. In both intervention groups the dynamic balance exercises focused on
controlling body posture in the forward, backward and sideward directions,
exploring limits of stability, shifting weight from one foot to another, sit-to-stand
movements, and included dual-task exercises. Patients worked in pairs, taking
turns performing the exercise while the other person rested. Two senior therapists
supervised training sessions, deﬁned training goals, and monitored training in-
tensity to ensure progressive overload throughout the training period. Participants
kept a training log for the duration of the training program.
2.4. Visual feedback training
The experimental group received VFT, which was explicitly integrated in each
workstation. Workstations consisted of a ﬂat-panel LCD monitor connected to a PC
containing a total of six, commercially available, interactive dynamic balance exer-
cises (Motek Medical, Amsterdam, The Netherlands; see Fig. 1). Movement regis-
tration using a force plate (Forcelink, Culemborg, The Netherlands) or inertial
sensors (Xsens, Enschede, The Netherlands) served to convert body movements to
motion of an object (‘avatar’) displayed on the monitor, allowing patients to move
within a virtual environment. Four exercises challenged control of body lean. They
varied with respect to the coupling between lean and avatar motion. For instance,
leaning forward would be associated with an increase in velocity of the avatar in
some exercises, with downwardmovement in another, and with upwardmovement
of the avatar in yet another exercise. The two remaining exercises were related to
more functional tasks associated with standing balance, namely taking a step and
performing a sit-to-stand movement. During the stepping exercise visual feedback
referred to foot placement, whereas during the sit-to-standmovement feedbackwas
related to upper body orientation while sitting, and related to upper leg orientation
while coming to stance. Each game allowed a number of parameters to be adjusted
so as to increase the difﬁculty (sensitivity to movement along each axis, speed,
duration).
2.5. Conventional balance training
For the control group the workstations consisted of balance exercises recom-
mended by the present Dutch guidelines for physical therapy in PD [14]. These
workstations focused on training standing balance and included exercises while
standing on one leg or with eyes closed, stepping exercises, dual-task exercises, sit-station with force plate and/or inertial sensor. B: Screenshots of examples of balance
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port surfaces.
2.6. Measurements and procedures
Assessments took place in a motion laboratory at the Faculty of Human Move-
ment Sciences of the VU University Amsterdam. Besides the clinimetric assessments
described in this report, combined posturographic and electroencephalographic
recordings were performed (not reported here [15]). The clinimetric test battery was
carried out according to current guidelines [14] and validated in a previous study
[17].
2.7. Outcomes
2.7.1. Primary outcome measure
The functional reach test (FRT), which measures the limits of stability as
perceived by the subject by assessing the difference between the length of the arm
and the maximal forward reach distance. The FRT provides a reliable and valid
assessment of standing balance [18] and, as far as the authors know, the only
established quantitative measure that addresses body lean.
2.7.2. Secondary outcome measures
a Balance and gait: the Berg Balance Scale [19], the single leg stance test [20], and
the 10 m walk test [21].
b Health status and level of activity and participation: Hoehn and Yahr stage, Uniﬁed
Parkinson Disease Rating Scale, parts I, II, III, and IV [22], the Falls Efﬁcacy Scale
[14,23], the Parkinson's Disease Questionnaire-39 [24], the Hospital Anxiety and
Depression [25], and the Multidimensional Fatigue Inventory [26].2.7.3. Descriptor variables
Age, disease duration, MMSE [27], fall status, and medication as recorded during
the ﬁrst assessment. A patient was categorized as a faller if he or she scored > 0 onFig. 2. Flowchaitem 13 of the UPDRS. Patients were asked at each subsequent visit whether their
medication had changed during the previous six weeks.
In their training log participants recorded each session's training load, rate of
perceived exertion, as well as any (near-) falls.
2.8. Randomization and blinding
Potential participants were selected from a local outpatient database and con-
tacted in order of waiting time. Participants were grouped in sets of six. Each set of
participants was allocated to either VFT or conventional therapy by drawing an
opaque sealed envelope from a pre-compiled random collection by an independent
investigator not involved in the present study.
Assessors were blinded for group allocation. Patients were instructed to refrain
from revealing treatment allocation to the assessors.
2.9. Statistical analysis
Statistical analyses were performed using IBM SPSS Statistics version 20 (IBM
Corp.). All outcomes were tested for group differences at baseline. Categorical
outcomemeasures were tested using Fisher's exact test if contingency tables were of
size 2  2, and the FishereFreemaneHalton test if tables were of larger size.
Continuous outcomemeasures were assessed for normality using the ShapiroeWilk
test and for equality of variance using Levene's test and analyzed by parametric or
nonparametric tests for independent samples, as appropriate. Nonparametric tests
were used for all other outcomes. The family-wise error rate was set at 0.05 by
means of the Bonferroni correction, requiring the individual two-tailed tests to be
evaluated at a ¼ 0.05/30 ¼ 0.0017 as threshold for signiﬁcance.
Differences in outcome measures between groups were assessed using change
scores for each interval (i.e. T1T0, and T2T1). These scores were subjected to a
ManneWhitney U test (non-parametric case) or an independent samples t-test
(parametric case), with group as between-subjects factor. Cohen's d is reported as
effect size for independent t-tests, while effect size for ManneWhitney U-tests was
calculated by dividing the obtained U value by the product of the two sample sizes
[28]. Data were assessed using an available-case analysis as well as intention-to-rt of trial.
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the worst-case scenario and the mean group change to do so in the best-case sce-
nario. The number of available cases was evaluated separately for each individual
outcome. In keeping with intention-to-treat analyses, subjects were entered into the
ﬁnal analyses irrespective of the number of attended sessions.
2.10. Ethical approval and informed consent
The protocol was approved by the Medical Ethics Committee of VUmc Amster-
dam and all patients signed informed consent.
3. Results
3.1. Trial proﬁle
A total of 33 patients were included in the trial (Fig. 2). Sixteen
patients received the control intervention and seventeen patients
received the VFT intervention. Both groups included one patient
who was treated using chronic deep brain stimulation. One patient
in the VFT group received intestinal levodopa infusion. One patient
in the VFT-group received an acetylcholinesterase inhibitor; no
patients received atypical antipsychotic drugs.
The median (interquartile range) number of attended sessions
was 9.0 (8.0e9.75) in the control group and 9.0 (8.0e10.0) in the
VFT-group. In the control group no subjects attended fewer than
seven training sessions. In the VFT group three subjects attended
fewer than seven sessions.
No falls or other adverse events were reported to have taken
place during the training sessions. One patient in the control group
dropped out because of health problems unrelated to PD; another
was excluded due to a change in medication prescription. One
subject was lost to follow-up as she could no longer be contacted,Table 1
Baseline comparison between groups for descriptor variables of all randomized patients.
third quartile); or number of patients per category. MMSE: Mini Mental State Examinat
posture and gait subscore; FRT: functional reach test; BBS: Berg balance scale; FES: falls ef
depression scale; MFI: multidimensional fatigue inventory.
Control center Dispersion
Gender [m/f] 8/8
Age [yrs] 68.8 ±9.68
Disease duration [yrs] 8.8 (2.50, 11.50)
L-dopa equivalence [mg/day] 722.8 ±441.25
MMSE 28.0 (26.00, 30.00)
HY
score 2.5 (2.00, 3.00)
1.5/2/2.5/3/3.5/4 0/5/5/6/0/0
Fallers [no/yes] 12/4
UPDRS
Total [0e199] 52.0 (35.25, 63.75)
I [0e16] 1.0 (1.00, 2.50)
II [0e52] 13.0 (9.00, 15.50)
III [0e112] 30.8 (19.00, 40.50)
IV [0e23] 6.0 (4.00, 7.50)
PG [0e20] 5.0 (3.00, 7.75)
FRT [cm] 27.14 ±9.61
BBS [0e56] 51.5 (47.50, 56.00)
Single leg stance [s]
Preferred 20.64 (5.79, 47.26)
Non, preferred 10.70 (4.17, 35.20)
10 m walk test
Walk speed [m/s] 1.21 ±0.26
Step length [m] 0.67 ±0.12
FES [0e30] 8.0 (2.00, 15.75)
PDQ-39 [0e100] 45.00 (18.13, 59.38)
HADS
Anxiety [0e21] 5.0 (3.25, 7.75)
Depression [0e21] 5.0 (3.50, 7.50)
MFI
General [4e20] 13.0 (11.25, 16.50)
Physical [4e20] 12.0 (11.00, 15.75)but was included in the analyses covering the intervention period.
Fourteen participants from the control group and seventeen from
the VFT group entered the ﬁnal analyses.
The average rating of perceived exertion during the training
sessions was 10.7 ± 2.4 (‘fairly light’) for the control group and
9.7 ± 2.2 for the VFT group (‘light’) and was not statistically sig-
niﬁcant different between groups (t(25) ¼ 1.446, p ¼ .161).
3.2. Baseline demographics
Baseline characteristics for randomized subjects are summa-
rized in Table 1. No signiﬁcant differences between the two groups
were observed at baseline (all p-values > 0.05).
3.3. Primary outcome
Table 2 shows the median change scores for the intervention
(T1T0) and follow-up periods (T2T1), for the available cases.
Change of the primary outcome measure FRT did not differ signif-
icantly between the groups (t(28) ¼ -0.116, p ¼ .908, d ¼ 0.043;
adjusted a ¼ 0.0017). Results for the intention-to-treat analysis
were similar.
3.4. Secondary outcomes
There were no statistically signiﬁcant differences in change
scores for any of the outcome measures (all p-values > 0.0017),
neither during intervention, nor during follow-up. For the balance-
related outcomes the non-signiﬁcant trends all favored VFT. Similar
results were obtained in the intention-to-treat analysis.Values indicate either the mean (±standard deviation); the median (ﬁrst quartile e
ion; HY: HoehneYahr stage; UPDRS: Uniﬁed Parkinson's Disease Rating Scale; PG:
ﬁcacy scale; PDQ-39: Parkinson's disease questionnaire; HADS: hospital anxiety and
VFT center Dispersion Statistic p
12/5 n/a 0.296
66.3 ±6.39 1.414 (29) 0.168
9.0 (4.00, 13.25) 98.5 0.415
716.9 ±453.46 0.435 (29) 0.667
29.0 (28.00, 30.00) 92.0 0.271
2.5 (2.00, 2.50) 111.0 0.734
0/6/8/3/0/0 1.737 0.469
8/9 n/a 0.157
46.0 (32.25, 62.00) 88.5 0.678
2.0 (1.00, 3.00) 68.5 0.168
12.0 (6.50, 17.50) 94.0 0.871
28.0 (17.75, 35.63) 113.5 0.827
4.0 (2.75, 6.50) 97.0 0.378
4.0 (3.00, 6.00) 93.5 0.852
26.38 ±6.72 0.233 (28) 0.817
53 (49.75, 55.00) 111.0 0.749
41.30 (13.75, 60.00) 96.5 0.366
18.86 (8.56, 41.36) 105 0.578
1.15 ±0.28 0.352 (29) 0.727
0.66 ±0.09 0.179 (29) 0.859
4.0 (1.00, 8.75) 76.0 0.319
23.75 (10.00, 35.00) 68.0 0.114
4.0 (1.50, 7.50) 87.0 0.453
3.5 (2.50, 6.00) 72.5 0.163
11.5 (8.50, 15.00) 84.5 0.390
11.0 (8.00, 14.50) 77.5 0.243
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The present pilot RCT is, as far as we know, the ﬁrst to investi-
gate the feasibility, safety and effectiveness of a balance training
program based on augmented visual feedback speciﬁcally designed
for patients with PD. Our results show that VFT is feasible for in-
dividuals with PD, safe to use and applicable in a group setting.
Adherence was comparable between groups, with all but three
subjects attending seven sessions or more. No adverse events were
reported throughout the trial and the two forms of training were
comparable in terms of perceived exertion. The therapists involved
in the training reported that VFT was well received by most par-
ticipants, with the element of scoring being particularly appreci-
ated. They also observed that mildly-affected patients could
operate the workstations independently, while more severely-
affected patients required some assistance and/or supervision. All
in all, the equipment was considered suitable for use in a (group)
setting where continuous one-on-one supervision is not required.
Use of the equipment in a home setting is, although technically
feasible, at present associated with substantial ﬁnancial costs.
Change scores related to balance outcomes all favored VFT, but
statistically signiﬁcant differences between groups could neither be
established for the primary outcome measure functional reach
distance, nor for any other measure. Hence, our ﬁndings do not
support the hypothesis that visual feedback-based balance training
is superior to conventional balance training in improving standing
balance performance as measured with the FRT.
VFT was not found to be superior to conventional training, but,
importantly, neither was it found to be inferior. These results are in
line with those reported for Wii-based training [13]. Equivalence of
treatments is an important consideration as VFT and other types of
game-based exercise could be associated with lower costs, greater
accessibility, and increased patient motivation [10].
As the trends for most outcomes favored VFT (Table 2), the
question arises whether this pilot RCT was powerful enough to
detect statistically signiﬁcant effects. Furthermore, only for the
outcome walking speed did the difference in change score
approach the minimal detectable change [21]. A power analysis for
this outcome revealed that in order to ﬁnd a signiﬁcant difference
between groups with a power of 0.8, each group should include at
least 61 subjects. Sample sizewas thus a limitation of this study. For
all other outcomes the magnitude of the improvements did not
appear to be clinically relevant, regardless of the type of interven-
tion. An ancillary analysis of within-group effects failed to show a
signiﬁcant treatment effect over time for either intervention. This
suggests that the ten-session training volume implemented in this
pilot study may have been insufﬁcient to elicit substantial training-
related improvements. Increasing treatment intensity by increasing
the number of sessions is hence the most likely option for
improving the interventions' effectiveness. In addition, the exer-
cises may need to be intensiﬁed in terms of adequate dose and level
of difﬁculty [6]. Participants from both groups rated their level of
exertion on average as ‘light’, indicating that there is room for an
increase in exercise intensity. Also, patients worked in pairs at each
workstation, which in the case of VFT meant a great reduction in
time spent practicing. In future forms of VFT this issue may be
resolved by the development of multiplayer games.
As indicated above, an important notion for future studies will
be to reconsider the choice of (primary) outcome measures. In
previous reports the FRT was shown to be responsive to treatment
and detect differences between groups of patients with PD [29,30],
but in hindsight the FRT measure, reﬂecting static leaning balance,
may be less suitable for changes induced by dynamic VFT. Alter-
natively, effects induced by the intervention may have been too
subtle to be identiﬁed by functional measures of balance. Though
M.R.C. van den Heuvel et al. / Parkinsonism and Related Disorders 20 (2014) 1352e1358 1357outside the scope of the present report, future analyses of com-
bined posturographic and EEG recordings that were part of the
study protocol may help reveal differential effects of training for
both groups [15].
To conclude, the results of our proof-of-principle study support
the notion that VFT in a group setting is safe and feasible for
providing therapeutic balance training to PD patients, albeit not
more effective than conventional therapy. While all trends in
change scores favored VFT, these differences did not reach statis-
tical signiﬁcance and were clinically meaningful only for a single
outcome measure. Though improved patient motivation may suf-
ﬁce to warrant the application of an equipment-intensive approach
such as VFT, future efforts should ﬁrst focus on improving the
intervention in order to strengthen its effects. This may be realized
by increasing the training load and by optimization of the
technology.
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